Jones David Scott sold ~$42M in EyePoint Pharmaceuticals, Inc. stock
EyePoint Pharmaceuticals, Inc. (EYPT) · SVP & Chief Commercial Officer · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
-5.5%vs SPY +9.6%
Trade Details · Public SEC Filing
Insider
Jones David Scott
Role
SVP & Chief Commercial Officer
Transaction
Open-Market Sale
Approx. Value
~$42M
Trade Date
Jan 8, 2024
Company
EyePoint Pharmaceuticals, Inc.
Ticker
EYPTSource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$42M sale
Trades over $1M are rare. When insiders put this much of their own money on the line, they tend to have high conviction in their company's direction.
SVP & Chief Commercial Officer
Senior executives have visibility into their division's pipeline and company health. Their trades carry weight because they understand the business from the inside.
4 insiders traded in the same window
When multiple insiders independently buy within 30 days, it's called a cluster. Studies show clustered insider purchases outperform solo trades significantly, because several people with inside knowledge are reaching the same conclusion.
-5.5% in 90 days (S&P 500: +9.6%)
This trade underperformed the S&P 500 by 15.2 percentage points. Not every insider trade wins. We track all of them so you can focus on the insiders with the best records.
How good is Jones David Scott at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
Jones David Scott wasn't the only one selling.
4 insiders at EyePoint Pharmaceuticals, Inc. traded within the same 30-day window.
See who else bought · FreeOn January 8, 2024, Jones David Scott — SVP & Chief Commercial Officer of EyePoint Pharmaceuticals, Inc. — filed a Form 4 with the SEC disclosing an open-market sale of approximately ~$42M in EyePoint Pharmaceuticals, Inc. (EYPT) stock.
This transaction was part of a cluster — 4 insiders at EyePoint Pharmaceuticals, Inc. made open-market sales within the same 30-day window. Cluster activity from multiple independent insiders is one of the most studied patterns in insider trading research.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, EYPT returned -5.5% versus +9.6% for the S&P 500 over the same period.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time Jones David Scott trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More EYPT Insider Activity
Zaderej Karen L.
May 19, 2025
~$177K
VS
Zaderej Karen L.
May 14, 2025
~$113K
STRONG
Cormorant Asset Management, LP
Jan 9, 2024
~$17M
STRONG
Lurker Nancy
Dec 4, 2023
~$23M
STRONG
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free